Group 1: Gilead Sciences Inc - Gilead Sciences reported a revenue of $6.4 billion for the last quarter, reflecting a 5% increase year-over-year [1] - The company’s antiviral drug sales, particularly for HIV and COVID-19 treatments, contributed significantly to the revenue growth [1] - Gilead's pipeline includes promising candidates for oncology and inflammatory diseases, which may enhance future growth prospects [1] Group 2: Applied Materials Inc - Applied Materials achieved a revenue of $6.2 billion, marking a 10% increase compared to the previous year [1] - The semiconductor equipment segment showed strong demand, driven by advancements in AI and 5G technologies [1] - The company anticipates continued growth in the semiconductor market, supported by increased capital expenditures from major customers [1] Group 3: Salesforce Inc - Salesforce reported a revenue of $7.4 billion, up 14% year-over-year, driven by strong demand for its cloud-based solutions [1] - The company’s focus on expanding its product offerings and enhancing customer experience has led to increased customer retention [1] - Salesforce is investing in AI capabilities to further enhance its platform, which is expected to drive future growth [1]